Treating hemorrhagic shock requires stopping the bleeding and replacing lost blood volume as quickly as possible. The approach depends on how much blood has been lost: losing up to 15% of total blood volume may need only monitoring and fluids, while losing more than 40% is immediately life-threatening and demands aggressive intervention including surgery and massive blood transfusion. Every step in treatment, from the first pressure applied to a wound to definitive surgery, is a race against a cascading series of physiological failures that become harder to reverse with each passing minute.
How Blood Loss Is Classified
Hemorrhagic shock is divided into four classes based on the percentage of total blood volume lost. An average adult has roughly 5 liters of blood, so even what sounds like a modest amount can push the body into dangerous territory.
- Class 1 (up to 750 mL, or 15%): Heart rate and blood pressure stay roughly normal. Most people wouldn’t even realize they’re bleeding internally at this stage.
- Class 2 (750 to 1,500 mL, or 15% to 30%): Heart rate climbs to 100 to 120 beats per minute. Blood pressure may still look normal, but the gap between the upper and lower numbers starts to narrow, which is an early warning sign.
- Class 3 (1,500 to 2,000 mL, or 30% to 40%): Blood pressure drops noticeably, heart rate exceeds 120, and confusion sets in. Urine output falls because the kidneys are no longer getting adequate blood flow.
- Class 4 (more than 2,000 mL, or over 40%): The pulse is rapid and weak, blood pressure collapses, and the person may be barely conscious or unresponsive. Urine output is minimal or absent.
Classes 3 and 4 require immediate, aggressive treatment. Class 2 can deteriorate quickly if the source of bleeding isn’t controlled, and even Class 1 warrants close monitoring because internal bleeding isn’t always obvious at first.
Stopping the Bleeding
Nothing else matters if the bleeding isn’t controlled. In the field, that means direct pressure, tourniquets on extremities, and wound-packing materials (some impregnated with clotting agents). For bleeding inside the chest, abdomen, or pelvis, the only definitive solution is surgery or a procedure to seal or clamp the damaged vessels.
One newer option for life-threatening abdominal or pelvic bleeding is a technique called REBOA, in which a small balloon is threaded through an artery and inflated inside the aorta to temporarily block blood flow below the injury site. It’s used when a patient is in profound shock or cardiac arrest from bleeding that can’t be compressed from the outside, such as liver, spleen, or kidney injuries, unstable pelvic fractures, or damaged abdominal blood vessels. Studies comparing REBOA to emergency chest surgery for circulatory collapse show lower mortality rates with the balloon approach (around 79% vs. 93%), though both carry extreme risk. REBOA is a bridge, not a fix. It buys time to get a patient into the operating room.
Blood Replacement and the 1:1:1 Ratio
For decades, the standard response to massive blood loss was to pour in saltwater solutions (crystalloids) to maintain blood pressure. That approach has largely been replaced by a strategy that gives back what was actually lost: whole blood components. The current standard, adopted by trauma centers worldwide, is a 1:1:1 ratio of red blood cells, plasma, and platelets. This balanced approach replaces not just the oxygen-carrying capacity of blood but also the clotting factors and proteins needed to stop bleeding and maintain circulation.
Crystalloid fluids still play a role in early resuscitation, but large volumes can dilute the blood’s remaining ability to clot, worsen swelling, and cool the body. The shift toward blood products given early and in balanced ratios has been one of the most significant changes in trauma care over the past two decades.
Permissive Hypotension
It sounds counterintuitive, but pushing blood pressure back to normal levels before the bleeding is controlled can actually make things worse. Higher pressure forces more blood out of damaged vessels and can dislodge clots that are starting to form. The current European guidelines recommend keeping systolic blood pressure at 80 to 90 mmHg (or a mean arterial pressure of 50 to 60 mmHg) until the source of bleeding is definitively repaired.
For penetrating injuries like stab or gunshot wounds, even lower targets may be appropriate: a systolic pressure of 60 to 70 mmHg. The exception is traumatic brain injury, where the brain needs higher perfusion pressure to avoid secondary damage. In those cases, providers aim for 80 to 90 mmHg systolic regardless of whether the trauma was penetrating or blunt. This deliberate acceptance of lower-than-normal blood pressure is called permissive hypotension, and it requires constant reassessment because the target changes the moment bleeding is controlled.
Tranexamic Acid and the 3-Hour Window
Tranexamic acid (TXA) is a medication that helps stabilize blood clots by preventing the body from breaking them down too quickly. It has become a standard part of hemorrhagic shock treatment, but timing is critical. Given within the first hour after injury, TXA significantly reduces the risk of death from bleeding. Given between one and three hours, it still helps but less dramatically. Given after three hours, it appears to increase the risk of death, likely because at that point the body’s clotting system has shifted in ways that make anti-breakdown drugs harmful.
The standard protocol is a 1-gram dose given as soon as possible, ideally while the patient is still being transported. A second 1-gram dose can be infused over eight hours, though some protocols now recommend holding that second dose until lab testing confirms the patient’s clotting system actually needs it.
The Lethal Triad
Severe hemorrhagic shock triggers three interconnected problems that feed off each other and can become fatal even after the bleeding itself is stopped. Trauma teams treat all three simultaneously.
Hypothermia
Blood loss, exposure, and cold fluids all drive body temperature down. In trauma patients, a core temperature below 35°C (95°F) is considered hypothermic. Cold blood doesn’t clot well, and cold muscles don’t maintain blood vessel tone, so hypothermia directly worsens bleeding. Treatment involves removing wet clothing, warming blankets, heated IV fluids, forced-air warming devices, and keeping ambulances and trauma bays at elevated temperatures.
Acidosis
When tissues don’t get enough oxygen, they switch to a backup energy system that produces acid as a byproduct. A blood pH below 7.35 signals acidosis, and it impairs the heart’s ability to pump, reduces the effectiveness of medications, and further disrupts clotting. The only real fix is restoring blood flow and oxygen delivery through transfusions, fluids, and sometimes medications that support blood pressure. Sodium bicarbonate can temporarily buffer the acid, but the acidosis returns unless the root cause (inadequate blood flow) is corrected.
Coagulopathy
The body’s clotting system breaks down during severe hemorrhage. Cold temperatures, acidic blood, and the dilution of clotting factors from fluid resuscitation all contribute. Patients whose blood takes significantly longer than normal to clot have mortality rates roughly three times higher than those with normal clotting. Treatment includes the 1:1:1 transfusion strategy, TXA, and in some cases concentrated clotting factors or fibrinogen supplements.
Each arm of this triad accelerates the other two. Hypothermia worsens coagulopathy, which increases bleeding, which deepens shock and acidosis, which makes the heart less effective, which cools the body further. Breaking this cycle early is the central challenge of hemorrhagic shock management.
Damage Control Surgery
When a patient is too physiologically unstable to tolerate a long, definitive operation, surgeons use a staged approach called damage control surgery. It unfolds in three phases.
The first phase is a rapid, abbreviated operation focused on two goals: stop life-threatening bleeding and prevent contamination from damaged bowels or other organs. Surgeons pack wounds, clamp vessels, and staple off injured bowel segments. The abdomen is often left temporarily open rather than sewn shut, because swelling can make closure dangerous.
The second phase takes place in the intensive care unit, where the focus shifts to correcting the lethal triad. The team warms the patient, replaces blood products, supports blood pressure, and works to normalize blood chemistry. This phase can last 24 to 48 hours or more.
The third phase is a return to the operating room for definitive repair once the patient is stable enough to tolerate it. Damaged organs are reconstructed or removed, blood vessels are permanently repaired, and the abdomen is closed. This staged approach has dramatically improved survival for the most severely injured patients, because it avoids the compounding damage of a prolonged operation on a body already in crisis.
Tracking Recovery With Lactate Levels
Lactate is the acid produced when tissues are starved of oxygen, and its level in the blood serves as a real-time indicator of how well resuscitation is working. A falling lactate level means tissues are getting oxygen again. A target of at least a 20% decrease in lactate every two hours over the first eight hours is associated with improved survival. If lactate levels plateau or continue to rise despite treatment, it signals that there’s ongoing bleeding, inadequate resuscitation, or a complication that hasn’t been identified yet. Trauma teams track this number closely as one of the most reliable guides for whether their interventions are working.